[Answered] The Durbin-Watson test tests for a.outliers b.nonnormality c.heteroscedasticity ...

This topic contains a solution. Click here to go to the answer

« previous next »

Author Question: The Durbin-Watson test tests for a.outliers b.nonnormality c.heteroscedasticity ... (Read 191 times)

drink

Hero Member
Posts: 554

on: Jul 24, 2018

The Durbin-Watson test tests for

a.outliers
b.nonnormality
c.heteroscedasticit y
d.nonindependence

Question 2

Which of the following parameters give the height at which the regression function,

, crosses the vertical axis?

b.x
c.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

juicepod

Sr. Member
Posts: 310

Reply #1 on: Jul 24, 2018

Answer to Question 1

correct: d

Answer to Question 2

correct: c

drink

Member
Posts: 554

Reply 2 on: Jul 24, 2018

TYSM

mochi09

Member
Posts: 335

Reply 3 on: Yesterday

Gracias!

« previous next »

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

The FDA recognizes 118 routes of administration.